97-110
Review Article
Treatment of invasive fungal infections in cancer patients—Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
Angelika Böhme, Markus Ruhnke, Dieter Buchheidt, Oliver A. Cornely and Herrmann Einsele, et al.
111-119
Original Article
Clinical features and prognostic factors of patients with “peripheral T cell lymphoma, unspecified”
Yuna Lee, Ji Eun Uhm, Hui-Young Lee, Min Jae Park and Hyeongsu Kim, et al.
121-132
Original Article
Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab
Thomas Elter, Janne J. Vehreschild, John Gribben, Oliver A. Cornely and Andreas Engert, et al.
133-139
Original Article
Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma
Lars Fischer, Agnieszka Korfel, Philipp Kiewe, Martin Neumann and Kristoph Jahnke, et al.
141-149
Original Article
Vitamin K deficiency amplifies anticoagulation response to ximelagatran: possible implications for direct thrombin inhibitors and their clinical safety
Farhad Kamali, Peter Wood and Alan Ward
151-158
Original Article
Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients
Andrea Camera, Ciro R. Rinaldi, Salvatore Palmieri, Nicola Cantore and Giuseppina Mele, et al.
159-166
Original Article
Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia
Guo-Rui Ruan, Jin-Lan Li, Ya-Zhen Qin, Ling-Di Li and Min Xie, et al.
167-172
Letter to the Editor
Efficiency of antiviral therapy plus IVIG in a case of primary EBV infection associated PTLD refractory to rituximab, chemotherapy, and antiviral therapy alone
R. Trappe, H. Riess, I. Anagnostopoulos, R. Neuhaus and B. C. Gärtner, et al.
173-175
Letter to the Editor
Chronic myeloid leukemia presenting late in pregnancy. Report of a case and a questionnaire reflecting diversity in management options
Magnus Björkholm, Lotta Ohm and Leif Stenke
177-178
Letter to the Editor
Splenic marginal zone lymphoma with Evans’ syndrome, autoimmunity, and peripheral gamma/delta T cells
Ricardo García-Muñoz, Paula Rodriguez-Otero, Carlota Pegenaute, Juana Merino and Juan Jakes-Okampo, et al.
179-180
Letter to the Editor
Erythropoietin for hemoglobin H disease
Olga M. Fortenko, Gretchen J. Schaef Johns and Ganesh C. Kudva
181-182
Letter to the Editor
Multiple myeloma presenting with spinal cord compression during pregnancy
John Quinn, Neil Rabin, Manuel Rodriguez-Justo, David Choi and Kwee Yong
183-184
Letter to the Editor
Hepatotoxicity as a rare but serious side effect of Thalidomide
Eric Levesque and Marc Bradette
185-187
Letter to the Editor
Non-nasal natural killer cell lymphoma: not non-nasal after all
Eric Tse, Rock Leung, Pek-Lan Khong, Wing-Hung Lau and Yok-Lam Kwong
189-191
Letter to the Editor
Progressive multifocal leuconcephalopathy and autoimmune haemolytic anemia in chronic lymphocytic leukaemia: more than a fortuitous combination?
Carlo Visco, Enrico Marchioni, Fabrizio Pomponi, Pasquale Ferrante and Serena Delbue, et al.